BC Week In Review | Sep 29, 2014
Company News

Ligand, CURx Pharmaceuticals deal

Ligand expanded an August 2013 deal with CURx to include the development and commercialization of Ligand's Captisol-enabled lamotrigine program. Under the expanded deal, Ligand will receive an undisclosed upfront payment and be eligible to receive...
Items per page:
1 - 1 of 1